Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tajikistan Health News.
Press releases published on August 6, 2025
Johnson & Johnson Innovative Medicine’s Tremfya Gains Momentum in Crohn’s Disease, Outpacing Eli Lilly’s Omvoh and Challenging AbbVie’s Skyrizi
GlobeNewswire
·
August 6, 2025
EXTON, PA, Aug. 06, 2025 (GLOBE NEWSWIRE) -- The Crohn’s disease (CD) treatment landscape is undergoing a radical transformation as newer mechanisms of action (MOAs), particularly IL-23 inhibitors and JAK inhibitors, continue displace long-standing …
Disarming a Hidden Killer: Predicting – and Preventing – C. diff Before It Strikes
GlobeNewswire
·
August 6, 2025
SEATTLE, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Clostridioides difficile (C. diff) is a stealthy threat. It infects more than 500,000 people in the United States each year, and kills up to 30,000. It is a leading cause of healthcare-associated infections, …
Beyond Gene Therapy: Pyruvate Kinase Activators (Agios, Novo Nordisk) Offer a New Route to Address Hemoglobin, VOCs, and Transfusion Burden in Sickle Cell Disease
GlobeNewswire
·
August 6, 2025
EXTON, PA, Aug. 06, 2025 (GLOBE NEWSWIRE) -- According to the latest findings from Spherix Global Insights’ syndicated Market Dynamix™ service, the US sickle cell disease (SCD) market is approaching a pivotal juncture, with gene therapies and novel oral …
APA Polling Shows Half of Adults Have Cut Back on Social Media Usage in 2025
GlobeNewswire
·
August 6, 2025
Washington, D.C., Aug. 06, 2025 (GLOBE NEWSWIRE) -- According to new polling from the American Psychiatric Association (APA), Americans’ relationship with technology is complicated: even as 62% of adults get anxious without access to their phone, two in …
Carestream Announces Improvements to Affordable, Digital-Ready Horizon X-ray System
GlobeNewswire
·
August 6, 2025
Rochester, N.Y., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Carestream Health today announced the addition of a new, six-way floating table for its Horizon X-ray System—helping provide significant benefits to patient positioning, workflow efficiency, and overall …
Brain Injury Association of America to Honor Centre for Neuro Skills’ Dr. Mark Ashley as Luminary of the Year
GlobeNewswire
·
August 6, 2025
BAKERSFIELD, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- The Brain Injury Association of America (BIAA) will honor Dr. Mark J. Ashley, Founder and Executive Chairman of the Board of Centre for Neuro Skills (CNS), as Luminary of the Year on Friday, November …
Cosmos Health Secures up to $300 Million Financing Facility to Launch Ethereum Treasury Strategy
GlobeNewswire
·
August 6, 2025
CHICAGO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, announced today that it has entered into a securities purchase agreement with a U. …
Dogwood Therapeutics to Report Second Quarter 2025 Financial Results on Wednesday, August 13, 2025
GlobeNewswire
·
August 6, 2025
ATLANTA, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), a development‐stage biotechnology company developing new medicines to treat pain and fatigue-related disorders, announced today that it will report second …
Distalmotion Marks Patient Enrollment Milestones in General Surgery and Gynecology Clinical Trials for the DEXTER® Robotic Surgery System
GlobeNewswire
·
August 6, 2025
Lausanne, Switzerland, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Distalmotion today announced continued momentum in its clinical trial plans to support indication expansion of its DEXTER® Robotic Surgery System in the U.S. This announcement—focused on ventral …
AIM ImmunoTech’s Oncology Drug Ampligen to Be Featured in Key Presentations and Abstract at the International 5th Annual Marie Skłodowska-Curie Symposium on Cancer Research and Care (MSCI MSCS-2025)
GlobeNewswire
·
August 6, 2025
There will be presentations on the latest positive progress from AIM’s clinical program in pancreatic cancer, the positive therapeutic effects of AIM’s drug Ampligen on multiple cancer types, and Ampligen’s mechanism of action in oncology Discussion will …
Capricor Therapeutics to Present Second Quarter 2025 Financial Results and Recent Corporate Update on August 13
GlobeNewswire
·
August 6, 2025
SAN DIEGO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced that it will release its financial …
PacBio to Present at Upcoming Investor Conferences
GlobeNewswire
·
August 6, 2025
MENLO PARK, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be participating in the following upcoming investor conferences: …
HealthEquity Announces Dates to Report Second Quarter Earnings and Presentations at Investor Conferences
GlobeNewswire
·
August 6, 2025
DRAPER, Utah, Aug. 06, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation’s largest health savings account (“HSA") custodian, today announced plans to release its second quarter of fiscal 2026 financial …
Femasys Secures First European Order for FemBloc, Marking Strategic Milestone in Global Expansion
GlobeNewswire
·
August 6, 2025
--Initiation of access to FemBloc, a revolutionary non-surgical permanent contraceptive, as global availability accelerates-- ATLANTA, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non- …
American Kidney Fund Expands ‘Me + C3G’ Campaign with New Resources to Help Patients Living with this Rare Kidney Disease
GlobeNewswire
·
August 6, 2025
ROCKVILLE, Md., Aug. 06, 2025 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) is pleased to announce the creation of new educational resources for “Me + C3G,” its educational campaign for the rare kidney disease complement 3 glomerulopathy (C3G). …
Actuate Therapeutics To Collaborate with Incyte Corporation and the University of Pittsburgh on Clinical Trial of Elraglusib in Combination with Retifanlimab and mFOLFIRINOX in Patients with Advanced Pancreatic Cancer
GlobeNewswire
·
August 6, 2025
Clinical Trial Study to be Conducted at UPMC Hillman Cancer to Evaluate Novel Combination as Frontline Therapy CHICAGO and FORT WORTH, Texas, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a …
Cingulate Submits New Drug Application to FDA for Lead ADHD Asset CTx-1301
GlobeNewswire
·
August 6, 2025
KANSAS CITY, Kan., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation …
Moleculin Biotech, Inc. Unveils Promising Preclinical Data of Annamycin in Liver Cancer Treatment
GlobeNewswire
·
August 6, 2025
Presented data highlights the potential of Annamycin for treating broad range of human cancers, including high-need oncology indications Annamycin currently in late-stage clinical development in combination with cytarabine for the treatment of AML; …
SeaStar Medical Reaches New Enrollment Milestone in NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury (AKI)
GlobeNewswire
·
August 6, 2025
Trial now over 60% enrolled with 125 of 200 anticipated patients Recent new site activation brings total clinical trial sites to 16 Interim analysis of first 100 patients remains on track for 3Q 2025 DENVER, Aug. 06, 2025 (GLOBE NEWSWIRE) -- SeaStar …
BiomX to Report Second Quarter 2025 Financial Results and Program Updates on August 13, 2025
GlobeNewswire
·
August 6, 2025
NESS ZIONA, Israel, Aug. 06, 2025 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced …